Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of pharmaceuticals targeting cancer and inflammatory diseases. Its structure allows selective modification to enhance binding affinity with specific enzyme targets. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to mimic purine bases in ATP-binding sites. Also utilized in the preparation of small-molecule drug candidates in preclinical research.